Dividend updates for key income funds

A series of income-focused exchange traded funds reported new dividend declarations on March 13, 2026, according to multiple notices. Several Accelerate Financial Technologies products listed on the Toronto Stock Exchange announced cash distributions in Canadian dollars, while a U.S. closed-end fund from Nuveen disclosed its latest monthly payout in U.S. dollars.

The Accelerate Arbitrage Fund ETF declared a cash dividend of CAD 0.26 per unit. Separate reports from Seeking Alpha and marketaux both cited the same amount and identified the fund by its TSX ticker symbol ARB:CA. The announcements focused on the size of the distribution, with no additional terms disclosed in the excerpts provided.

Alongside the arbitrage strategy, the Accelerate Diversified Credit Income Fund ETF declared a dividend of CAD 0.14. This payout level applied both to the unhedged version, referenced under the TSX ticker INCM:CA, and to the Diversified Credit Income Fund Hedged ETF, cited under ticker INCM.B:CA in a separate marketaux notice.

The Accelerate Absolute Return Hedge Fund ETF also announced a distribution, declaring a dividend of CAD 0.10. A parallel CAD 0.10 payout was reported for the Accelerate OneChoice Alternative Multi-Asset Fund ETF. Both declarations were noted in Seeking Alpha items, indicating that multiple Accelerate alternative and multi-asset strategies set cash distributions on the same reporting date.

In the U.S. municipal bond segment, the Nuveen Quality Municipal Income Fund reported a cash dividend of $0.0705. The notice, published by Seeking Alpha, specified the per-share amount but did not include further details such as record or payment dates within the provided excerpt.

Outside of income announcements, other brief items highlighted sector and single-stock developments. One Seeking Alpha update stated that SDHC was at high risk of performing badly, without elaborating on the underlying metrics or time horizon behind that assessment.

Another note reported a quant ratings roundup as fertilizer stocks rallied on Middle East supply fears. The item indicated that concerns about supply from the region were coinciding with gains in fertilizer-related equities, with quant-based evaluations being tracked for the group.

In healthcare, Johnson & Johnson (JNJ) was reported to have hit the main goal in an early-stage trial for a drug delivery system. The brief update did not specify the therapeutic area or trial design details, but indicated that the primary objective for the system was met at this stage of development.